NCT05903703 Canagliflozin With Gemcitabine in Pancreatic Carcinoma Status NOT_YET_RECRUITING Phase NA
NCT05886075 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors Status UNKNOWN Phase EARLY_PHASE1
NCT05872867 Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) Status RECRUITING Phase PHASE1
NCT05864144 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05861336 GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer Status WITHDRAWN Phase PHASE2
NCT05860374 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT05859750 A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT05842187 In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer Status UNKNOWN Phase NA
NCT05837767 A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue Status RECRUITING Phase NA
NCT05836870 Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05831488 Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer Status UNKNOWN Phase N/A
NCT05827796 IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05810792 Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05802420 The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer Status UNKNOWN Phase NA
NCT05802407 The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer Status RECRUITING Phase NA
NCT05802394 The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer Status RECRUITING Phase NA
NCT05784311 Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) Status RECRUITING Phase PHASE4